Skip to content
The People's CodeSearch
Menu

Changes to the Code

S. 4189 · Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 ·

INSULIN Act of 2026

Reported by committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

21 U.S.C. § 355 New drugs

+38 −3815 of 17 shown
More for 21 U.S.C. § 355
Read § 355Only this section
17 changes the bill asks for here, 15 carried out
  1. Carried out:

    in subparagraph (A)(i), by inserting , 10.31, after 10.30;

  2. Carried out:

    by striking application and and inserting application or;

  3. Carried out:

    by striking If the Secretary and inserting the following:(i) In general.— If the Secretary; and

  4. Not carried out:

    by striking the second sentence and inserting the following:(ii) Primary purpose of delaying.— (I) In general.— In determining whether a petition was submitted with the primary purpose of delaying an application, the Secretary may consider the following factors: (aa) Whether the petition was submitted in accordance with paragraph (2)(B), …

    We can't read how this instruction is worded yet, so it isn't shown in the text.

    Technical detailno-pattern: striking the second sentence and inserting the following: QCONTENT;
  5. Carried out:

    by striking subparagraph (F);

  6. Carried out:

    by redesignating subparagraphs (G) through (I) as subparagraphs (F) through (H), respectively; and

  7. Carried out:

    in subparagraph (G), as so redesignated, by striking submission of this petition and inserting submission of this document;

  8. Carried out:

    by redesignating subparagraphs (A) through (C) as subparagraphs (C) through (E), respectively;

  9. Carried out:

    by inserting before subparagraph (C), as so redesignated, the following:(A) In general.— A person shall submit a petition to the Secretary under paragraph (1) before filing a civil action in which the person seeks to set aside, delay, rescind, withdraw, or prevent submission, review, or approval of an application submitted under subsection (b)(2) or …

  10. Carried out:

    in the heading, by striking within 150 days;

  11. Carried out:

    in clause (i), by striking during the 150-day period referred to in paragraph (1)(F),; and

  12. Carried out:

    by amending clause (ii) to read as follows:(ii) on or after the date that is 151 days after the date of submission of the petition, the Secretary approves or has approved the application that is the subject of the petition without having made such a final decision.;

  13. Carried out:

    by amending subparagraph (D), as so redesignated, to read as follows:(D) Dismissal of certain civil actions.— (i) Petition.— If a person files a civil action against the Secretary in which a person seeks to set aside, delay, rescind, withdraw, or prevent submission, review, or approval of an application submitted under subsection (b)(2) or (j) of …

  14. Carried out:

    in clause (iii) of subparagraph (E), as so redesignated, by striking as defined under subparagraph (2)(A) and inserting within the meaning of subparagraph (C); and

  15. Not carried out:

    by striking Exceptions in the paragraph heading and all that follows through This subsection does and inserting Exceptions.—This subsection does;

    The bill strikes from “Exceptions” through “This subsection does” in § 355(q)(4), but “This subsection does” doesn't come after “Exceptions” there.

    Technical detail“This subsection does” does not follow “Exceptions” in /us/usc/t21/s355/q/4
  16. Carried out:

    by striking subparagraph (B); and

  17. Carried out:

    by redesignating clauses (i) and (ii) as subparagraphs (A) and (B), respectively, and adjusting the margins accordingly.

§ 355(q)(1)(A)Determination(i)–(ii)

Start of § 355 to (q)(1) unchanged ·

(A) Determination The Secretary shall not delay approval of a pending application submitted under subsection (b)(2) or (j) of this section or section 262(k) of title 42 because of any request to take any form of action relating to the application, either before or during consideration of the request, unless—

(i) the request is in writing and is a petition submitted to the Secretary pursuant to section 10.30[inserted: ,] [inserted: 10.31, ]or 10.35 of title 21, Code of Federal Regulations (or any successor regulations); and

(ii) the Secretary determines, upon reviewing the petition, that a delay is necessary to protect the public health.

Consideration of the petition shall be separate and apart from review and approval of any application.

§ 355(q)Petitions and civil actions regarding approval of certain applications(1)–(3)

(q)(1)(B)–(C) unchanged ·

(D) Public disclosure Any information conveyed by the Secretary under subparagraph (C) shall be considered part of the application and shall be subject to the disclosure requirements applicable to information in such application.

(E) Denial based on intent to delay

(i) [inserted: In general.—] [inserted: If the Secretary determines that a petition or a supplement to the petition was submitted with the primary purpose of delaying the approval of an application or the petition does not on its face raise valid scientific or regulatory issues, the Secretary may deny the petition at any point based on such determination. The Secretary may issue guidance to describe the factors that will be used to determine under this subparagraph whether a petition is submitted with the primary purpose of delaying the approval of an application.]

[struck: If the Secretary determines that a petition or a supplement to the petition was submitted with the primary purpose of delaying the approval of an application and the petition does not on its face raise valid scientific or regulatory issues, the Secretary may deny the petition at any point based on such determination. The Secretary may issue guidance to describe the factors that will be used to determine under this subparagraph whether a petition is submitted with the primary purpose of delaying the approval of an application.]

[struck: (F)] [struck: Final agency action] [struck: The Secretary shall take final agency action on a petition not later than 150 days after the date on which the petition is submitted. The Secretary shall not extend such period for any reason, including—]

[struck: (i)] [struck: any determination made under subparagraph (A);]

[struck: (ii)] [struck: the submission of comments relating to the petition or supplemental information supplied by the petitioner; or]

[struck: (iii)] [struck: the consent of the petitioner.]

[struck: (G)] [inserted: (F)] Extension of 30-month period If the filing of an application resulted in first-applicant status under subsection (j)(5)(D)(i)(IV) and approval of the application was delayed because of a petition, the 30-month period under such subsection is deemed to be extended by a period of time equal to the period beginning on the date on which the Secretary received the petition and ending on the date of final agency action on the petition (inclusive of such beginning and ending dates), without regard to whether the Secretary grants, in whole or in part, or denies, in whole or in part, the petition.

[struck: (H)] [inserted: (G)] Certification The Secretary shall not consider a petition for review unless the party submitting such petition does so in written form and the subject document is signed and contains the following certification: “I certify that, to my best knowledge and belief: (a) this petition includes all information and views upon which the petition relies; (b) this petition includes representative data and/or information known to the petitioner which are unfavorable to the petition; and (c) I have taken reasonable steps to ensure that any representative data and/or information which are unfavorable to the petition were disclosed to me. I further certify that the information upon which I have based the action requested herein first became known to the party on whose behalf this petition is submitted on or about the following date: __________. If I received or expect to receive payments, including cash and other forms of consideration, to file this information or its contents, I received or expect to receive those payments from the following persons or organizations: _____________. I verify under penalty of perjury that the foregoing is true and correct as of the date of the submission of this [struck: petition][inserted: document].”, with the date on which such information first became known to such party and the names of such persons or organizations inserted in the first and second blank space, respectively.

[struck: (I)] [inserted: (H)] Verification The Secretary shall not accept for review any supplemental information or comments on a petition unless the party submitting such information or comments does so in written form and the subject document is signed and contains the following verification: “I certify that, to my best knowledge and belief: (a) I have not intentionally delayed submission of this document or its contents; and (b) the information upon which I have based the action requested herein first became known to me on or about __________. If I received or expect to receive payments, including cash and other forms of consideration, to file this information or its contents, I received or expect to receive those payments from the following persons or organizations: _____. I verify under penalty of perjury that the foregoing is true and correct as of the date of the submission of this petition.”, with the date on which such information first became known to the party and the names of such persons or organizations inserted in the first and second blank space, respectively.

(2) Exhaustion of administrative remedies

(A) [inserted: In general.—] [inserted: A person shall submit a petition to the Secretary under paragraph (1) before filing a civil action in which the person seeks to set aside, delay, rescind, withdraw, or prevent submission, review, or approval of an application submitted under subsection (b)(2) or (j) of this section or section 351(k) of the Public Health Service Act. Such petition and any supplement to such a petition shall describe all information and arguments that form the basis of the relief requested in any civil action described in the previous sentence.]

(B) [inserted: Timely submission of citizen petition.—] [inserted: A petition and any supplement to a petition shall be submitted within 180 days after the person knew the information that forms the basis of the request made in the petition or supplement.]

[struck: (A)] [inserted: (C)] Final agency action[struck: within 150 days] The Secretary shall be considered to have taken final agency action on a petition if—

(i) [struck: during ]the [struck: 150-day period referred to in paragraph (1)(F), the ]Secretary makes a final decision within the meaning of section 10.45(d) of title 21, Code of Federal Regulations (or any successor regulation); or

(ii) [struck: such][inserted: on] [struck: period][inserted: or] [struck: expires][inserted: after] [struck: without][inserted: the] [inserted: date that is 151 days after ]the [inserted: date of submission of the petition, the ]Secretary [inserted: approves or has approved the application that is the subject of the petition without ]having made such a final decision.

[struck: (B)] [inserted: (D)] Dismissal of certain civil actions[inserted: .—]

(i) [inserted: Petition.—] [inserted: If a person files a civil action against the Secretary in which a person seeks to set aside, delay, rescind, withdraw, or prevent submission, review, or approval of an application submitted under subsection (b)(2) or (j) of this section or section 351(k) of the Public Health Service Act without complying with the requirements of subparagraph (A), the court shall dismiss without prejudice the action for failure to exhaust administrative remedies.]

(ii) [inserted: Timeliness.—] [inserted: If a person files a civil action against the Secretary in which a person seeks to set aside, delay, rescind, withdraw, or prevent submission, review, or approval of an application submitted under subsection (b)(2) or (j) of this section or section 351(k) of the Public Health Service Act without complying with the requirements of subparagraph (B), the court shall dismiss with prejudice the action for failure to timely file a petition.]

(iii) [inserted: Final response.—] [inserted: If a civil action is filed against the Secretary with respect to any issue raised in a petition timely filed under paragraph (1) in which the petitioner requests that the Secretary take any form of action that could, if taken, set aside, delay, rescind, withdraw, or prevent submission, review, or approval of an application submitted under subsection (b)(2) or (j) of this section or section 351(k) of the Public Health Service Act before the Secretary has taken final agency action on the petition within the meaning of subparagraph (C), the court shall dismiss without prejudice the action for failure to exhaust administrative remedies.]

[struck: If a civil action is filed against the Secretary with respect to any issue raised in the petition before the Secretary has taken final agency action on the petition within the meaning of subparagraph (A), the court shall dismiss without prejudice the action for failure to exhaust administrative remedies.]

[struck: (C)] [inserted: (E)] Administrative record For purposes of judicial review related to the approval of an application for which a petition under paragraph (1) was submitted, the administrative record regarding any issue raised by the petition shall include—

(i) the petition filed under paragraph (1) and any supplements and comments thereto;

(ii) the Secretary’s response to such petition, if issued; and

(iii) other information, as designated by the Secretary, related to the Secretary’s determinations regarding the issues raised in such petition, as long as the information was considered by the agency no later than the date of final agency action [struck: as][inserted: within] [struck: defined][inserted: the] [struck: under][inserted: meaning] [inserted: of ]subparagraph ([struck: 2][inserted: C])[struck: (A)], and regardless of whether the Secretary responded to the petition at or before the approval of the application at issue in the petition.

(3) Annual report on delays in approvals per petitions The Secretary shall annually submit to the Congress a report that specifies—

(A) the number of applications that were approved during the preceding 12-month period;

§ 355(q)Petitions and civil actions regarding approval of certain applications(4)–(5)

(q)(3)(B)–(D) unchanged ·

(4) Exceptions

(A) This subsection does not apply to—

[struck: (i)] [inserted: (A)] a petition that relates solely to the timing of the approval of an application pursuant to subsection (j)(5)(B)(iv); or

[struck: (ii)] [inserted: (B)] a petition that is made by the sponsor of an application and that seeks only to have the Secretary take or refrain from taking any form of action with respect to that application.

[struck: (B)] [struck: Paragraph (2) does not apply to a petition addressing issues concerning an application submitted pursuant to section 262(k) of title 42.]

(5) Definitions

(A) Application For purposes of this subsection, the term “application” means an application submitted under subsection (b)(2) or (j) of this section or section 262(k) of title 42.

Rest of § 355 unchanged ·

26 U.S.C. § 9815 Additional market reforms

+1 −1Shown
More for 26 U.S.C. § 9815
Read § 9815Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 9815(a)(1) of the Internal Revenue Code of 1986 is amended by inserting and the INSULIN Act of 2026 after Affordable Care Act.

§ 9815(a)–(b)

§ 9815.1 Additional market reforms

(a) General rule Except as provided in subsection (b)—

(1) the provisions of part A of title XXVII of the Public Health Service Act (as amended by the Patient Protection and Affordable Care Act[inserted: and the INSULIN Act of 2026]) shall apply to group health plans, and health insurance issuers providing health insurance coverage in connection with group health plans, as if included in this subchapter; and

(2) to the extent that any provision of this subchapter conflicts with a provision of such part A with respect to group health plans, or health insurance issuers providing health insurance coverage in connection with group health plans, the provisions of such part A shall apply.

(b) Exception Notwithstanding subsection (a), the provisions of sections 2716 and 2718 of title XXVII of the Public Health Service Act (as amended by the Patient Protection and Affordable Care Act) shall not apply with respect to self-insured group health plans, and the provisions of this subchapter shall continue to apply to such plans as if such sections of the Public Health Service Act (as so amended) had not been enacted.

29 U.S.C. § 1185d Additional market reforms

+1 −1Shown
More for 29 U.S.C. § 1185d
Read § 1185dOnly this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 715(a)(1) of the Employee Retirement Income Security Act of 1974 (29 U.S.C. 1185d(a)(1)) is amended by inserting and the INSULIN Act of 2026 after Affordable Care Act.

§ 1185d(a)–(b)

§ 1185d. Additional market reforms

(a) General rule Except as provided in subsection (b)—

(1) the provisions of part A of title XXVII of the Public Health Service Act [42 U.S.C. 300gg et seq.] (as amended by the Patient Protection and Affordable Care Act[inserted: and the INSULIN Act of 2026]) shall apply to group health plans, and health insurance issuers providing health insurance coverage in connection with group health plans, as if included in this subpart; and

(2) to the extent that any provision of this part conflicts with a provision of such part A with respect to group health plans, or health insurance issuers providing health insurance coverage in connection with group health plans, the provisions of such part A shall apply.

(b) Exception Notwithstanding subsection (a), the provisions of sections 2716 and 2718 of title XXVII of the Public Health Service Act [42 U.S.C. 300gg–16, 300gg–18] (as amended by the Patient Protection and Affordable Care Act) shall not apply with respect to self-insured group health plans, and the provisions of this part shall continue to apply to such plans as if such sections of the Public Health Service Act (as so amended) had not been enacted.

42 U.S.C. § 262 Regulation of biological products

+28 −0Shown
More for 42 U.S.C. § 262
Read § 262Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 351(k) of the Public Health Service Act (42 U.S.C. 262(k)) is amended by adding at the end the following:(10) Expediting biosimilar competition.— (A) In general.— The Secretary may, at the request of the sponsor of an application under this subsection for licensure of a biosimilar biological product that is designated as a competitive biosimilar biological product pursuant to …

§ 262(k)–(l)

Start of § 262 to (k)(9)(B) unchanged ·

(i) the biological product shall be immediately removed from such list for the same period as the revocation or suspension; and

(ii) a notice of the removal shall be published in the Federal Register.

(10) [inserted: Expediting biosimilar competition.—]

(A) [inserted: In general.—] [inserted: The Secretary may, at the request of the sponsor of an application under this subsection for licensure of a biosimilar biological product that is designated as a competitive biosimilar biological product pursuant to subparagraph (B), expedite the development and review of such application under this subsection.]

(B) [inserted: Designation process.—]

(i) [inserted: Request.—] [inserted: The sponsor of an application under this subsection may request the Secretary to designate the drug as a competitive biosimilar biological product. A request for such designation may be made concurrently with, or during the 60-day period immediately prior to, the submission of a biosimilar biological product license application under this subsection.]

(ii) [inserted: Criteria.—] [inserted: A biosimilar biological product is eligible for designation as a competitive biosimilar biological product under this paragraph if the Secretary determines that there is inadequate biosimilar competition.]

(iii) [inserted: Designation.—] [inserted: Not later than 60 calendar days after the receipt of a request under clause (i), the Secretary may—]

(I) [inserted: determine whether the biosimilar biological product that is the subject of the request meets the criteria described in clause (ii); and]

(II) [inserted: if the Secretary finds that such product meets such criteria, designate the biosimilar biological product as a competitive biosimilar biological product.]

(C) [inserted: Inadequate biosimilar competition.—] [inserted: In this paragraph, the term “inadequate biosimilar competition” means that, with respect to a biological product licensed under subsection (a)—]

(i) [inserted: on the list published under paragraph (9)(A) (not including biological products on the discontinued section of such list), there are fewer than 3 biological products licensed under this subsection pursuant to an application that uses such biological product licensed under subsection (a) as a reference product; and]

(ii) [inserted: not less than 3 years have passed since the expiration of all exclusivity periods applicable to such biological product licensed under subsection (a), or applicable to a biosimilar biological product licensed under this subsection using such biological product licensed under subsection (a) as a reference product, including any exclusivity periods under—]

(I) [inserted: paragraph (6);]

(II) [inserted: paragraph (7)(A);]

(III) [inserted: section 527 of the Federal Food, Drug, and Cosmetic Act; and]

(IV) [inserted: subsection (m).]

(l) Patents

(1) Confidential access to subsection (k) application

(A) Application of paragraph Unless otherwise agreed to by a person that submits an application under subsection (k) (referred to in this subsection as the “subsection (k) applicant”) and the sponsor of the application for the reference product (referred to in this subsection as the “reference product sponsor”), the provisions of this paragraph shall apply to the exchange of information described in this subsection.

Rest of § 262 unchanged ·

42 U.S.C. § 18022 Essential health benefits requirements

+11 −0Shown
More for 42 U.S.C. § 18022
Read § 18022Only this section
2 changes the bill asks for here, 2 carried out
  1. Carried out:

    Section 1302(d)(2) of the Patient Protection and Affordable Care Act (42 U.S.C. 18022(d)(2)) is amended by adding at the end the following new subparagraph:(D) Special rule relating to insulin coverage.— For plan years beginning on or after January 1, 2028, the exemption of coverage of selected insulin products (as defined in section 2729A of the Public Health Service Act) from the application of any deductible pursuant to section …

  2. Carried out:

    Section 1302(e) of the Patient Protection and Affordable Care Act (42 U.S.C. 18022(e)) is amended by adding at the end the following:(4) Coverage of certain insulin products.— (A) In general.— Notwithstanding paragraph (1)(B)(i), for plan years beginning on or after January 1, 2028, a health plan described in paragraph (1) shall provide coverage of selected insulin products, in accordance with section 2729A …

§ 18022(d)Levels of coverage(2)–(4)

Start of § 18022 to (d)(2)(A) unchanged ·

(B) Employer contributions The Secretary shall issue regulations under which employer contributions to a health savings account (within the meaning of section 223 of title 26) may be taken into account in determining the level of coverage for a plan of the employer.

(C) Application In determining under this title,1 the Public Health Service Act [42 U.S.C. 201 et seq.], or title 26 the percentage of the total allowed costs of benefits provided under a group health plan or health insurance coverage that are provided by such plan or coverage, the rules contained in the regulations under this paragraph shall apply.

(D) [inserted: Special rule relating to insulin coverage.—] [inserted: For plan years beginning on or after January 1, 2028, the exemption of coverage of selected insulin products (as defined in section 2729A of the Public Health Service Act) from the application of any deductible pursuant to section 2729(a)(1) of such Act shall not be treated as increasing the actuarial value of a plan when determining the actuarial value of a qualified health plan under this subsection.]

(3) Allowable variance The Secretary shall develop guidelines to provide for a de minimis variation in the actuarial valuations used in determining the level of coverage of a plan to account for differences in actuarial estimates.

(4) Plan reference In this title,1 any reference to a bronze, silver, gold, or platinum plan shall be treated as a reference to a qualified health plan providing a bronze, silver, gold, or platinum level of coverage, as the case may be.

§ 18022(e)–(g)

(e) unchanged ·

(ii) section 5000A(e)(5) of such title (relating to individuals with hardships).

(3) Restriction to individual market If a health insurance issuer offers a health plan described in this subsection, the issuer may only offer the plan in the individual market.

(4) [inserted: Coverage of certain insulin products.—]

(A) [inserted: In general.—] [inserted: Notwithstanding paragraph (1)(B)(i), for plan years beginning on or after January 1, 2028, a health plan described in paragraph (1) shall provide coverage of selected insulin products, in accordance with section 2729A of the Public Health Service Act, before an enrolled individual has incurred, during the plan year, cost-sharing expenses in an amount equal to the annual limitation in effect under subsection (c)(1) for the plan year.]

(B) [inserted: Terminology.—] [inserted: For purposes of subparagraph (A)—]

(i) [inserted: the term “selected insulin products” has the meaning given such term in section 2729A(b) of the Public Health Service Act; and]

(ii) [inserted: the requirements of section 2729A of such Act shall be applied by deeming each reference in such section to “individual health insurance coverage” to be a reference to a plan described in paragraph (1).]

(f) Child-only plans If a qualified health plan is offered through the Exchange in any level of coverage specified under subsection (d), the issuer shall also offer that plan through the Exchange in that level as a plan in which the only enrollees are individuals who, as of the beginning of a plan year, have not attained the age of 21, and such plan shall be treated as a qualified health plan.

(g) Payments to Federally-qualified health centers If any item or service covered by a qualified health plan is provided by a Federally-qualified health center (as defined in section 1396d(l)(2)(B) of this title) to an enrollee of the plan, the offeror of the plan shall pay to the center for the item or service an amount that is not less than the amount of payment that would have been paid to the center under section 1396a(bb) of this title) for such item or service.

Step through the changes